Cancentus Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Cancentus General Information
Description
Developer of selective cancer therapeutics and AI-driven drug discovery services designed to exploit oncogene-induced DNA replication stress in tumor cells. The company's pipeline of next-generation antibody-drug conjugate payloads, selective helicase inhibitors, and rational combination therapies targets replication stress vulnerabilities alongside in silico hit identification and lead optimization, enabling patients to achieve higher treatment efficacy with lower off-target toxicity.
Contact Information
Website
www.cancentus.comCorporate Office
- C/O Switzerland Innovation Park Basel Area
- Hegenheimermattweg 167A
- 4123 Allschwil
- Switzerland
Corporate Office
- C/O Switzerland Innovation Park Basel Area
- Hegenheimermattweg 167A
- 4123 Allschwil
- Switzerland
Cancentus Timeline
Cancentus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 14-Apr-2026 | Completed | Generating Revenue | |||
| 2. Grant | 20-Aug-2025 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2025 | Completed | Generating Revenue |
Cancentus Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BaseLaunch | Accelerator/Incubator | Minority | ||
| University of Basel | University | |||
| University of Geneva | University |
Cancentus FAQs
-
When was Cancentus founded?
Cancentus was founded in 2025.
-
Where is Cancentus headquartered?
Cancentus is headquartered in Allschwil, Switzerland.
-
What industry is Cancentus in?
Cancentus’s primary industry is Biotechnology.
-
Is Cancentus a private or public company?
Cancentus is a Private company.
-
What is Cancentus’s current revenue?
The current revenue for Cancentus is .
-
Who are Cancentus’s investors?
BaseLaunch, University of Basel, and University of Geneva have invested in Cancentus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process